Brázda Václav, Klusáková Ilona, Svízenská Ivana, Veselková Zuzana, Dubový Petr
Department of Anatomy, Division of Neuroanatomy, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic.
Cell Mol Neurobiol. 2009 Sep;29(6-7):1053-62. doi: 10.1007/s10571-009-9396-0. Epub 2009 Mar 28.
Local intracellular signaling cascades following peripheral nerve injury lead to robust axon regeneration and neuropathic pain induction. Cytokines are classic injury-induced mediators. We used sciatic nerve ligature (ScNL) to investigate temporal changes in IL-6 and its receptor gp130 in both ipsilateral and contralateral lumbal (L4-L5) dorsal root ganglia (DRG). Rats were operated aseptically on unilateral ScNL and allowed to survive for 1, 3, 7, and 14 days. Immunohistochemistry and Western blot analysis were used to determine levels of IL-6 and gp130 in DRG. A distinct increase in immunostaining for IL-6 was found in the neuronal cell bodies of sections through both ipsilateral and contralateral DRG at 1 and 3 days after operation. After 7 and 14 days, the DRG sections displayed only a moderate elevation in immunostaining when compared with sections of naïve DRG. The levels of IL-6 protein increased in both ipsilateral and contralateral lumbal DRG following peripheral nerve injury. The elevation of IL-6 protein was significant in both ipsilateral and contralateral DRG 1, 3, 7, and 14 days after operation. On the other hand, the levels of gp130 receptor did not change significantly. The data provide evidence for changes in IL-6 levels not only in the DRG associated with the damaged nerve but also in those unassociated with nerve injury during the experimental neuropathic pain model.
外周神经损伤后局部细胞内信号级联反应会导致强大的轴突再生和神经性疼痛的诱发。细胞因子是典型的损伤诱导介质。我们采用坐骨神经结扎术(ScNL)来研究白细胞介素-6(IL-6)及其受体gp130在同侧和对侧腰段(L4-L5)背根神经节(DRG)中的时间变化。对大鼠进行单侧ScNL无菌手术,并使其存活1、3、7和14天。采用免疫组织化学和蛋白质印迹分析来测定DRG中IL-6和gp130的水平。术后1天和3天,在同侧和对侧DRG切片的神经元细胞体中发现IL-6免疫染色明显增加。7天和14天后,与未损伤DRG切片相比,DRG切片仅显示免疫染色适度升高。外周神经损伤后,同侧和对侧腰段DRG中IL-6蛋白水平均升高。术后1、3、7和14天,同侧和对侧DRG中IL-6蛋白的升高均具有显著性。另一方面,gp130受体水平没有明显变化。这些数据为在实验性神经性疼痛模型中,不仅在与受损神经相关的DRG中,而且在与神经损伤无关的DRG中IL-6水平的变化提供了证据。